Fulcrum Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Fulcrum Therapeutics, Inc. has filed 478 SEC EDGAR filings since 25 Jul 2016

SEC filing history

Showing 376-400 of 478 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
04 Jun 2020
Reporting date
02 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2020
Reporting date
01 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 May 2020
Reporting date
27 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38978

8-K

Filing date
13 May 2020
Reporting date
13 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38978

DEFA14A

Filing date
29 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38978

DEF 14A

Filing date
29 Apr 2020
Reporting date
11 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38978

8-K

Filing date
02 Apr 2020
Reporting date
02 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-236910

S-8

Filing date
05 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38978

8-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Feb 2020
Reporting date
19 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Feb 2020
Reporting date
19 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91080

SC 13G filing

Filing date
20 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91080

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91080

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .